SAN vs. CM: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2196900/san-vs-cm-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2196900
Dec 12, 2023 - SAN vs. CM: Which Stock Is the Better Value Option?
0
BridgeBio submits FDA market application for ATTR-CM drug
https://seekingalpha.com/news/4043524-bridgebio-submits-fda-market-application-for-attr-cm-drug?source=feed_sector_healthcare
Dec 05, 2023 - BridgeBio (BBIO) has submitted a New Drug Application to the FDA for acoramidis, a potential treatment for ATTR-CM. Read more here.
0